California State Teachers Retirement System (CalSTRS)’s VistaGen Therapeutics VTGN Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio VTGN Stock Details VTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,565	Closed	-$9.6K	–	3210
2023 Q1	$9.6K	Sell	2,565 -189	-7%	-$991	﹤0.01%	3024
2022 Q4	$8.51K	Buy	2,754 +192	+7%	+$723	﹤0.01%	3060
2022 Q3	$12K	Sell	2,562 -214	-8%	-$2.12K	﹤0.01%	3081
2022 Q2	$73K	Buy	2,776 +13	+0.5%	+$459	﹤0.01%	2965
2022 Q1	$103K	Sell	2,763 -790	-22%	-$34.4K	﹤0.01%	2861
2021 Q4	$208K	Buy	3,553 +113	+3%	+$7.35K	﹤0.01%	2774
2021 Q3	$283K	Sell	3,440 -5,366	-61%	-$466K	﹤0.01%	2620
2021 Q2	$832K	Buy	+8,806	New	+$652K	﹤0.01%	2330

Other funds holding VTGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s VTGN Position: Q2 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of VistaGen Therapeutics (VTGN) in Q2 2023, closing a stake of 2,565 shares — an estimated $9.6K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in VTGN in Q2 2021 and held it in 8 quarters. The position peaked at $832K in Q2 2021. 33 funds tracked by Wall St. Rank hold VTGN as of Q2 2023.

California State Teachers Retirement System (CalSTRS) reported no remaining VistaGen Therapeutics position as of Q2 2023 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 2,565 VistaGen Therapeutics shares in Q2 2023, an estimated $9.6K.
California State Teachers Retirement System (CalSTRS) first reported a position in VistaGen Therapeutics in Q2 2021 and held it in 8 quarters.
California State Teachers Retirement System (CalSTRS)'s VistaGen Therapeutics position peaked at $832K in Q2 2021.
33 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.